XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.21.4

SHAREHOLDERS' EQUITY | 3 Months Ended
--- | ---
Nov. 30, 2021
SHAREHOLDERS' EQUITY [Abstract] |
SHAREHOLDERS' EQUITY | NOTE 7 – SHAREHOLDERS’ EQUITY The Company reserved 1.6 million shares of common stock for issuance to employees and directors pursuant to the Company’s 2014 Equity Incentive Plan (2014 Equity Plan). As of November 30, 2021 and August 31, 2021, there were 876,665 and 974,965 shares available for grant under the 2014 Equity Plan. Prior to the effective date of the 2014 Equity Plan, the Company granted options and stock awards to eligible participants under its 2004 Incentive Plan (2004 Incentive Plan), which expired on April 11, 2014. No additional awards may be granted pursuant to the 2004 Incentive Plan. The following table summarizes the combined stock option activity for the 2004 Incentive Plan and 2014 Equity Plan for the three months ended November 30, 2021:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ |  | Approximate
​ |  | ​ |  | ​ | ​ |  | Weighted Average |  | Aggregate
​ | ​ | Number | ​ | Weighted Average | ​ | Remaining | ​ | Intrinsic Value
​ |  | of Options |  | Exercise Price |  | Contractual Term |  | (in thousands)
Outstanding at August 31, 2021 |  | 714,500 | ​ | $ | 7.80 |  | 6.06 | ​ | $ | 5,107
Granted |  | 105,000 | ​ | $ | 13.37 |  |  | ​ |  |
Net settlement exercised |  | (13,167) | ​ | $ | 7.81 |  |  | ​ |  |
Outstanding at November 30, 2021 |  | 806,333 | ​ | $ | 8.53 |  | 6.32 | ​ | $ | 4,864
​ |  |  | ​ |  |  |  |  | ​ |  |
Options exercisable at November 30, 2021 |  | 570,002 | ​ | $ | 7.42 |  | 5.18 | ​ | $ | 4,070
​ During the three months ended November 30, 2021, the Company had net settlement exercises of stock options, whereby the optionee did not pay cash for the options but instead received the number of shares equal to the difference between the exercise price and the market price on the date of exercise. Net settlement exercises during the three months ended November 30, 2021 resulted in 6,467 shares issued and 6,700 options cancelled in settlement of shares issued. The following table summarizes the combined activity and value of non-vested options under the 2004 Equity Plan and 2014 Incentive Plan as for the three months ended November 30, 2021:
​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted Average
​ |  | Number |  | Grant Date
​ |  | of Options |  | Fair Value
Non-vested options outstanding at August 31, 2021 |  | 218,333 | ​ | $ | 4.04
Granted |  | 105,000 | ​ | $ | 5.16
Vested |  | (87,002) | ​ | $ | 4.21
Non-vested options outstanding at November 30, 2021 (a) |  | 236,331 | ​ | $ | 4.48
(a) | All non-vested options are expected to vest.
For each of the three months ended November 30, 2021 and 2020, the Company recorded $0.1 million of stock-based compensation expense. At November 30, 2021, the Company had unrecognized compensation expenses totaling $1.0 million relating to non-vested options that are expected to vest. The weighted-average period over which these options are expected to vest is approximately two and a half years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration